CABALETTA BIO INC (CABA)

US12674W1099 - Common Stock

15.2  +0.5 (+3.4%)

After market: 15.6 +0.4 (+2.63%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CABA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.2. This target is 32.87% above the current price.
CABA was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CABA.
In the previous month the buy percentage consensus was at a similar level.
CABA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 15.2014.1417.3420.2035.70 - -6.97% 14.08% 32.87% 134.87%
Up and Down Grades
Date Firm Action Rating
2023-09-18 Wells Fargo Maintains Overweight -> Overweight
2023-09-05 Citigroup Initiate Buy
2023-08-14 Guggenheim Reiterate Buy -> Buy
2023-08-11 HC Wainwright & Co. Maintains Buy -> Buy
2023-07-18 Guggenheim Initiate Buy
2023-05-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-03 HC Wainwright & Co. Reiterate Buy
2023-04-10 HC Wainwright & Co. Reiterate Buy
2023-04-03 HC Wainwright & Co. Reiterate Buy
2023-03-22 Chardan Capital Reiterate Buy
2023-03-17 Mizuho Reiterate Buy
2023-03-17 HC Wainwright & Co. Maintains Buy
2023-02-17 HC Wainwright & Co. Reiterate Buy
2023-01-27 Morgan Stanley Upgrade Equal-Weight -> Overweight
2023-01-03 Wells Fargo Maintains Overweight
2022-11-11 Chardan Capital Maintains Buy
2022-09-14 Wells Fargo Maintains Overweight
2022-08-30 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-08-12 Chardan Capital Maintains Buy
2022-05-25 Mizuho Maintains Buy
2021-12-15 Morgan Stanley Maintains Overweight
2021-12-08 Wells Fargo Initiate Overweight
2021-06-30 Mizuho Initiate Buy
2021-03-17 HC Wainwright & Co. Maintains Buy